FDA Approved Products
6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
AMOXIL
amoxicillin
LOE Approaching
Pfizer
ORAL · TABLET, CHEWABLE
the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of the designated bacteria in the conditions listed below: 1duodenal ulcer recurrence
1999
NDA30/100
AMOXIL
amoxicillin
LOE Approaching
Pfizer
ORAL · TABLET
the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of the designated bacteria in the conditions listed below: 1duodenal ulcer recurrence
1998
NDA30/100
AMOXIL
amoxicillin
LOE Approaching
Pfizer
ORAL · TABLET, CHEWABLE
the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of the designated bacteria in the conditions listed below: 1duodenal ulcer recurrence
1980
NDA30/100
AMPHOTEC
amphotericin b
LOE Approaching
INJECTION · INJECTABLE, LIPID COMPLEX
invasive aspergillosis in patients where renal impairmentunacceptable toxicity precludes the use of amphotericin B deoxycholate in effective doses
1996
NDA30/100
AMPYRA
dalfampridine
LOE Approaching
Merz Therapeutics
ORAL · TABLET, EXTENDED RELEASE
walking in adult patients with multiple sclerosis (MS)multiple sclerosis
2010
NDA30/100
AMRIX
cyclobenzaprine hydrochloride
LOE Approaching
Teva
ORAL · CAPSULE, EXTENDED RELEASE
2007
NDA30/100
AMTURNIDE
aliskiren hemifumarate; amlodipine besylate; hydrochlorothiazide
LOE Approaching
Novartis
ORAL · TABLET
hypertension in adultsgreater+4
2010
NDA30/100
AMVAZ
amlodipine maleate
LOE Approaching
Dr. Reddy's Laboratories
ORAL · TABLET
2003
NDA30/100
AN-DTPA
technetium tc-99m pentetate kit
LOE Approaching
Jubilant Therapeutics
INJECTION · INJECTABLE
1976
NDA30/100
AN-SULFUR COLLOID
technetium tc 99m sulfur colloid
LOE Approaching
PharmaIN
INJECTION, ORAL · SOLUTION
breast cancermelanoma
1978
NDA30/100
ANADROL-50
oxymetholone
LOE Approaching
ORAL · TABLET
1972
NDA30/100
ANAFRANIL
clomipramine hydrochloride
LOE Approaching
ORAL · CAPSULE
obsessionscompulsions in patients with Obsessive-Compulsive Disorder (OCD)
1989
NDA30/100
ANAPROX
naproxen sodium
LOE Approaching
ORAL · TABLET
rheumatoid arthritis
1980
NDA30/100
ANAPROX DS
naproxen sodium
LOE Approaching
ORAL · TABLET
minor achespains due to: minor pain of arthritis muscular aches backache menstrual cramps headache toothache the common cold temporarily reduces fever
1980
NDA30/100
ANCEF
cefazolin sodium
LOE Approaching
GSK
INJECTION · INJECTABLE
respiratory tract infections due to Streptococcus pneumoniaeStaphylococcus aureus+15
1973
NDA30/100
ANCOBON
flucytosine
LOE Approaching
Bausch + Lomb
ORAL · CAPSULE
1971
NDA30/100
ANDRODERM
testosterone
LOE Approaching
AbbVie
TRANSDERMAL · FILM, EXTENDED RELEASE
1995
NDA30/100
ANDROGEL
testosterone
LOE Approaching
Besins Healthcare
TRANSDERMAL · GEL
2000
NDA30/100
ANECTINE
succinylcholine chloride
LOE Approaching
Novartis
INJECTION · INJECTABLE
mechanical ventilation ()
1952
NDA30/100
ANGIO-CONRAY
iothalamate sodium
LOE Approaching
INJECTION · INJECTABLE
1996
NDA30/100
ANHYDRON
cyclothiazide
LOE Approaching
Eli Lilly and Company
ORAL · TABLET
1963
NDA30/100
ANSAID
flurbiprofen
LOE Approaching
Pfizer
ORAL · TABLET
rheumatoid arthritis
1988
SMNDA30/100
ANTABUSE
disulfiram
LOE Approaching
Teva
ORAL · TABLET
1951
NDA30/100
ANTEPAR
piperazine citrate
LOE Approaching
GSK
ORAL · TABLET
1957
NDA30/100